Funding Opportunity

Pfizer Acromegaly Research

Information about the funding opportunity

Acromegaly:
o Morbidity and mortality in Growth Hormone Excess
o Impact and/or needs of patients with Growth Hormone Excess
during the pediatric, transitional years and young adult life
o Novel strategies including Quality of Life and Patient Reported
Outcomes to evaluate and treat Growth Hormone Excess
o Early diagnosis and treatment of Growth Hormone Excess
o Pathophysiology of Growth Hormone Excess and/or deficiency
and/or action